<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01150279</url>
  </required_header>
  <id_info>
    <org_study_id>6.1.3</org_study_id>
    <nct_id>NCT01150279</nct_id>
  </id_info>
  <brief_title>Exploring the Role of At-home Semi-Quantitative Pregnancy Tests for Medical Abortion Follow-up</brief_title>
  <official_title>Simplifying Medical Abortion Provision: Exploring the Role of At-home Semi-Quantitative Pregnancy Tests for Medical Abortion Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Secretaría de Salud del Distrito Federal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Office National de la Famille et de la Population, Tunisia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maternité de la Rabta, Tunisia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinique du Parc, Tunisia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <brief_summary>
    <textblock>
      This study will examine the feasibility, acceptability and usability of a semi-quantitative
      urine pregnancy test (dBest One Step hCG Panel Test Kit) for at-home follow-up after early
      medical abortion using mifepristone+misoprostol. The study seeks to:

        1. Assess the feasibility of using this test in lieu of standard one-week clinic-based
           follow up for determination of complete abortion status as part of normal service
           delivery. In Mexico, follow up will be in two weeks, as is standard care in that .

        2. To determine if women using this test at home understand how to use it and can correctly
           interpret the results; is it practical.

        3. Assess women's and provider's acceptability of using at-home pregnancy tests in lieu of
           clinic-based follow up for confirmation of complete medical abortion in the future.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of women who correctly interpreted their results (in U.S. and Vietnam only)</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent of women who felt confident in using the test and would be willing to use it in place of clinic-based follow up in the future</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of times the provider believes that each participant correctly read her test result</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of providers who were comfortable with the urine pregnancy test determining whether women need to return or not for clinic-based follow-up</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of times that the semi-quantitative test correctly identifies all on going pregnancies</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">1200</enrollment>
  <condition>Medical Abortion</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Women presenting to clinic seeking medical abortion
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women age greater than or equal to 18 years

          -  Gestational age less than or equal to 63 days by last menstrual period (LMP),
             ultrasound or clinical assessment

          -  Agrees to return for follow-up visit and willing to provide an address and/or
             telephone number for purposes of follow-up

          -  Able to consent to study participation.

        Inclusion Criteria for Mexico:

          -  Gestational age &lt;_ 70 days from LMP

          -  Eligible for mifepristone- misoprostol medical abortion according to clinic guidelines

          -  Willing to follow instructions of the provider regarding use of the at-home pregnancy
             test

          -  Agrees to provide test results by phone to study coordinator on morning of schedule
             follow-up visit

          -  Willing to provide an address and/or telephone number for purposes of follow-up

          -  Agrees to return for standard follow-up visit

          -  Wishes to participate in the study

          -  Having easy access to a telephone and transportation

          -  Able to consent to study participation

        Exclusion Criteria:

          -  Women less than 18 years of age

          -  Women not eligible for medical abortion services

          -  Women unable to provide contact information

          -  Women unable to sign the consent form

        Exclusion Criteria for Mexico:

          -  Women not eligible for medical abortion services

          -  Women unable to provide contact information

          -  Women unable to sign the consent form
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul D Blumenthal, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Beverly Winikoff, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Blum, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynuity Health Investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patricio Sanhueza Smith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Secretaría de Salud del Distrito Federal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rym Fayala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Office National de la Famille et de la Population</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ezzedine Sfar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternité de la Rabta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hella Chelli</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique du Parc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rasha Dabash, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Planned Parenthood Mar Monte</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Planning Associates Group - Washington</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Planning Associates- Elston</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Materno Infantil Nicolas M. Cedillo</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ONFP Ben Arous</name>
      <address>
        <city>Ben Arous</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ONFP Nabeul</name>
      <address>
        <city>Nabeul</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ONFP Sousse</name>
      <address>
        <city>Sousse</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Parc</name>
      <address>
        <city>Tunis</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternite de la Rabta</name>
      <address>
        <city>Tunis</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HocMon District Hospital</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
    <country>Tunisia</country>
    <country>United States</country>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2010</study_first_submitted>
  <study_first_submitted_qc>June 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2010</study_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>medical abortion</keyword>
  <keyword>Medical Abortion Follow Up Care</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

